Walleye Capital
INSM icon

Walleye Capital’s Insmed INSM Stock Holding History

Walleye Capital’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.78M Sell
23,100
-9,500
-29% -$1.46M 0.02% 987
2025
Q4 		$5.67M Sell
32,600
-26,600
-45% -$4.85M 0.02% 1055
2025
Q3 		$8.53M Buy
59,200
+48,100
+433% +$5.89M 0.03% 620
2025
Q2 		$1.12M Buy
11,100
+7,600
+217% +$581K ﹤0.01% 1964
2025
Q1 		$267K Sell
3,500
-65,300
-95% -$5M ﹤0.01% 3035
2024
Q4 		$4.75M Buy
68,800
+25,200
+58% +$1.81M 0.01% 1111
2024
Q3 		$3.18M Buy
+43,600
New +$3.22M 0.01% 1532
2023
Q2 		– Sell
-20,600
Closed -$351K – 4568
2023
Q1 		$351K Buy
+20,600
New +$400K 0.01% 1988
2019
Q3 		– Sell
-22,000
Closed -$563K – 2051
2019
Q2 		$563K Buy
+22,000
New +$613K 0.06% 446

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Walleye Capital's INSM Position: Q1 2026 in Review

Walleye Capital increased its Insmed (INSM) stake by 354% in Q1 2026, buying an estimated $8.61M and bringing the position to 71,819 shares worth $11.7M. The position accounts for 0.05% of the portfolio, ranked #342.

Walleye Capital first reported a position in INSM in Q4 2021 and has held it in 15 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Walleye Capital held 71,819 shares of Insmed worth $11.7M as of Q1 2026.
  • Walleye Capital bought 55,999 Insmed shares in Q1 2026, an estimated $8.61M.
  • Insmed made up 0.05% of Walleye Capital's portfolio in Q1 2026, its #342 holding.
  • Walleye Capital first reported a position in Insmed in Q4 2021 and has held it in 15 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.